Brain Cancer Syngeneic Models

Explore Brain Cancer Syngeneic Models:

Model NameDescription
GL261A C57BL/6 glioma model with moderate immunogenicity, widely used for evaluating immunotherapies and CNS-targeted agents.
CT2AA poorly immunogenic, rapidly growing C57BL/6 glioma model suitable for testing immune-modulating and cytotoxic therapies.
SMA-560A syngeneic astrocytoma model in VM/Dk mice, characterized by infiltrative CNS growth and relevance for brain tumour immuno-oncology studies.